Image

Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

This is an exploratory experimental multicentre study on archived serum samples and on prospectively collected serum samples and blood samples.

General objectives of the study are: to identify specific biomarkers in order to develop more accurate serological tests for the screening of Leishmania infections that does not present cross-reaction with other infectious diseases; to unveil the Antigen Recognition Patterns (ARPs) of Leishmania infection in humans; to verify whether the ARPs and the new biomarkers are common to different Leishmania infantum strains isolated in Italy as well as in other part of the World and to different strains of L. donovani isolated in Sudan as well as in other part of the World and discard any possible cross reaction with other infectious diseases such as Chagas, TB, leprosy or malaria.

Eligibility

CASES

Inclusion criteria:

  • Leishmania positive patient from Italy (n=30) and from Sudan (n=30);
  • patient with a clinically or laboratory confirmed diagnosis of leishmaniasis;
  • signed informed consent (criteria not applied in case of samples stored at the Tropica Biobank at the DITM)
  • being clinically classified as leishmaniasis patient by an experienced clinician or being laboratory confirmed as leishmaniasis patients, giving positive to at least two different serological tests or to a molecular test for Leishmania sp.
  • adult subjects (equal or older than 18 years)

Exclusion criteria:

  • lack of the necessary data and/or of biological samples
  • subjects younger than 18 years

COMMUNITY CONTROLS:

Inclusion criteria:

  • Cryo-preserved serum samples stored at the Tropica Biobank at the DITM , IRCCS Sacro Cuore Don Calabria Hospital, Negrar (Vr), from subject from Italy (n=30) and from Africa (n=30) with no infection due by Leishmania spp.
  • signed informed consent to Tropica Biobank
  • adult subjects (equal or older than 18 years)
  • being negative to two different serological tests for leishmaniasis

Exclusion criteria:

  • subjects younger than 18 years
  • being positive to one serological tests for leishmaniasis.

VALIDATION CONTROLS (VC):

Inclusion criteria:

  • serum samples stored in Tropica Biobank at the DITM from subjects that have been clinically diagnosed with Chagas's disease, or TB, or malaria or leprosy.
  • informed consent signed to Tropical Biobank
  • adult subjects (equal or older than 18 years)
  • being negative to two different serological tests for leishmaniasis.
  • being clinically diagnosed with Chagas disease or TB, or malaria or leprosy

Exclusion criteria:

  • younger than 18 years
  • positive result to one serological test for leishmaniasis.

Study details

Leishmaniasis

NCT06307171

IRCCS Sacro Cuore Don Calabria di Negrar

21 March 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.